Eva Asp

As Senior Director of Molecular & Cell Biology at Triplet Therapeutics, Inc., Eva Asp leads a team of scientists to develop assays to screen therapeutics to treat triplet repeat disorders. Prior to joining Triplet, Eva worked at Proclara Biosciences where she developed therapeutics to treat neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. Eva holds a M.S in Genetics and a Ph.D. in molecular biology from Gothenburg University, Sweden.